Publications by authors named "P Y Ting"

Background/objectives: Alcohol consumption and poor dietary habits are on the rise in the United States, posing significant challenges to public health due to their contribution to chronic diseases such as liver failure. While associations between alcohol consumption patterns and diet quality have been explored, the relationship between specific alcoholic beverage types and diet quality remains underexamined. This study aims to compare diet quality among consumers of different alcoholic beverage types.

View Article and Find Full Text PDF

Sickle cell disease (SCD) is a prevalent, life-threatening condition with few treatment options, attributed to a heritable mutation in β-hemoglobin. Therapeutic induction of fetal hemoglobin (HbF) with small molecules has been pursued as a treatment to ameliorate many disease complications but with limited success. Herein, we report the discovery of , a novel, potent, and selective molecular glue degrader of the transcription factor WIZ that robustly induces HbF expression as a potential treatment for SCD.

View Article and Find Full Text PDF
Article Synopsis
  • Obesity is a significant risk factor for chronic diseases, with a study analyzing its prevalence in different regions and occupations in China, revealing a rapid increase and social inequalities.
  • Data from over 62,000 adults across 10 provinces in 2022 showed an average BMI of 23.81 kg/m with 34.29% overweight and 11.24% obese; North China had the highest obesity rates, particularly among functionaries and workers compared to other occupation types.
  • The study indicated that metabolic health is poor among obese individuals, suggesting the need for tailored public health strategies to address the growing obesity crisis and its complications in China.
View Article and Find Full Text PDF
Article Synopsis
  • - Sickle cell disease (SCD) is a serious inherited condition caused by a mutation in the β-hemoglobin gene, and increasing fetal hemoglobin (HbF) levels can help reduce complications.
  • - Researchers discovered two small molecules, dWIZ-1 and dWIZ-2, that act as molecular glue degraders to induce HbF by targeting a previously unrecognized repressor, the WIZ transcription factor.
  • - These compounds effectively triggered HbF production in animal models, suggesting that targeting WIZ for degradation offers a promising and accessible new treatment approach for SCD.
View Article and Find Full Text PDF